PTEN function is frequently lost in prostate cancer and a recent study demonstrated aberrations in the PTEN gene in 41% of 150 individuals with metastatic, castration-resistant prostate cancer in a large multiinstitutional sequencing study18. The gene discussed is PTEN; the disease is prostate carcinoma.